*/imgres?imgurl=https://european-biotechnology.com/wp-content/uploads/2024/04/guido-oelkers.jpg&imgrefurl=https://european-biotechnology.com/appointments/sobi-business-man/&h=473&w=420&tbnid=K5aDpLApAWUYfM&q=Guido+Oelkers&tbnh=129&tbnw=115&usg=AI4_-kQn-NUwxY3h93ImA1ZzTZyNDbV0UQ&vet=1&docid=mXJP7p2mnZzXpM&hl=fi&sa=X&ved=2ahUKEwjo-o_40uyIAxXqGxAIHb33J-4Q9QF6BAgAEAQ)
*/imgres?imgurl=https://www.egonzehnder.com/cdn/serve/article-images/1579727243-78dfd0fcf0fd170428edb2cb1d1e2773.jpg&imgrefurl=https://www.egonzehnder.com/annual-health-industry-leaders-dinner&h=731&w=756&tbnid=ZhrLMl8k1uEl7M&q=Guido+Oelkers&tbnh=137&tbnw=142&usg=AI4_-kSmhFT4BB0R8qWYLW1JVf8mIPEv9w&vet=1&docid=w4ORUS8IueLFOM&hl=fi&sa=X&ved=2ahUKEwjo-o_40uyIAxXqGxAIHb33J-4Q9QF6BAgAEAY)
*/imgres?imgurl=https://nordiclifescience.org/wp-content/uploads/2020/10/guido-oelkers-e1602667186369.jpg&imgrefurl=https://nordiclifescience.org/sobi-study-did-not-meet-primary-endpoints/&h=400&w=800&tbnid=1fuXoojtsFF75M&q=Guido+Oelkers&tbnh=72&tbnw=143&usg=AI4_-kT5dLd_DEK63r-rtTyqP-6CccyqQA&vet=1&docid=ECBXaI_FIPDpfM&hl=fi&sa=X&ved=2ahUKEwjo-o_40uyIAxXqGxAIHb33J-4Q9QF6BAgAEAg)
*/imgres?imgurl=https://image.nordjyske.dk/users/nordjyske/images/83566277.jpg?t%5Bstrip%5D%3Dtrue%26t%5Bresize%5D%5Bwidth%5D%3D3830%26t%5Bresize%5D%5Bheight%5D%3D2619%26accessToken%3D09c6b7254d39e8a57f6570b7a9c053e69b2bec9f6ee3d6b587e52c65a3815a98&imgrefurl=https://www.lifesciencesweden.se/article/view/1029655/sobis_vd_om_miljardforvarvet_ger_bade_tillvaxt_och_marginal&h=2619&w=3830&tbnid=3AfYDC-q8fPbUM&q=Guido+Oelkers&tbnh=103&tbnw=150&usg=AI4_-kTjH10naHrZ4dNBbtSfWbGJaENMmQ&vet=1&docid=QpYtI1dMEKcpXM&hl=fi&sa=X&ved=2ahUKEwjo-o_40uyIAxXqGxAIHb33J-4Q9QF6BAgAEAo)
*/imgres?imgurl=https://nordiclifescience.org/wp-content/public_html/2021/09/guido_oelkers-e1630919895713.png&imgrefurl=https://nordiclifescience.org/sobi-to-cease-refacto-manufacturing/&h=399&w=760&tbnid=2eamj8a6eYnBWM&q=Guido+Oelkers&tbnh=75&tbnw=142&usg=AI4_-kSPK4jH1MrDOWS7ESXBHFGQ6lQfGA&vet=1&docid=ZLjFvK49FIIauM&hl=fi&sa=X&ved=2ahUKEwjo-o_40uyIAxXqGxAIHb33J-4Q9QF6BAgAEAw)
*/imgres?imgurl=https://medtech.citeline.com/-/media/editorial/headshots/corporate/o/oelkers_guido_1200.jpg?rev%3D21eb1a829adc46918983528dec8e5256%26w%3D790%26hash%3D0DDD185DF39D0662424B277AE9EBB53F&imgrefurl=https://medtech.citeline.com/SC098874/Sobis-Niche-Distribution-Platform-No-Longer-For-Sale&h=444&w=790&tbnid=twZBlAIbdYmAAM&q=Guido+Oelkers&tbnh=80&tbnw=143&usg=AI4_-kSQH78tHg5I7p-8IvlBBZhVq5PnhQ&vet=1&docid=2RABsVRZQWvMkM&hl=fi&sa=X&ved=2ahUKEwjo-o_40uyIAxXqGxAIHb33J-4Q9QF6BAgAEA4)
Guido Oelkers. Chief Executive Officer. Chief Executive Officer; employed since 2017. Born 1965; German national. Education: PhD in strategic management ...
4.5.2024 · Says Oelkers has extensive experience from pharmaceutical and health care companies including a role as President and CEO of the Swedish ...
Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Dr. Oelkers is President & Chief Executive Officer for Swedish Orphan ...
Guido Oelkers, Ph.D., is the Chief Executive Officer of Swedish Orphan Biovitrum since 2017. Prior to that, he worked for BSN medical.
Guido Oelkers is Chief Executive Officer at Swedish Orphan Biovitrum AB. See Guido Oelkers's compensation, career history, education, & memberships.
Download image 5.33 MB · Contacts · Careers · Healthcare professionals · Liberate Life. Follow us. Linkedin · Cookie policy · Privacy notice · Website terms ...
How to be a Successful CEO in a Private Equity Owned Company
www.egonzehnder.com › annual-health-i...
Oelkers is a well-known leader in the health industry with experience across pharma, biotech, and medical device companies, including BSN Medical, Gambro, ...
1.8.2024 · The CEO & President, Guido Oelkers, recently sold a substantial kr59m worth of stock at a price of kr293 per share. That sale reduced their total holding by 38 ...
News stories and articles referencing Guido Oelkers on European Pharmaceutical Review.